Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

3.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.8K
Neural Regulation01:37

Neural Regulation

43.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.9K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.5K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The clinical manifestation and neural correlates of cognitive-motor interference in Parkinson's disease.

NPJ Parkinson's disease·2026
Same author

Characteristics, predictors, and management of post-extubation dysphagia in critically Ill children: a scoping review.

Frontiers in pediatrics·2026
Same author

Baseline amyloid deposition phenotypes inform the spatial distribution of early amyloid clearance with lecanemab in Alzheimer's disease.

European journal of nuclear medicine and molecular imaging·2026
Same author

Differentiating tremor-dominant parkinson's disease from essential tremor using neuromelanin- sensitive imaging and T1w/T2w ratio.

NPJ Parkinson's disease·2026
Same author

Disrupted dynamic brain network and its functional topological underpinning in essential tremor.

Neurobiology of disease·2026
Same author

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Related Experiment Video

Updated: Mar 9, 2026

Formulating and Characterizing an Exosome-based Dopamine Carrier System
06:08

Formulating and Characterizing an Exosome-based Dopamine Carrier System

Published on: April 4, 2022

3.8K

Exosomes in Parkinson's Disease.

Xiaoqing Wu1, Tingting Zheng2, Baorong Zhang3

  • 1Department of Neurology, Xinchang People's Hospital, Xinchang, 312500, China.

Neuroscience Bulletin
|December 28, 2016
PubMed
Summary

Exosomes, tiny vesicles in the central nervous system, show promise as biomarkers and drug delivery vehicles for Parkinson's disease (PD). Research highlights their role in spreading toxic proteins and potential therapeutic applications.

Keywords:
BiomarkerExosomesParkinson’s diseasePathologyTherapy

More Related Videos

Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma
07:34

Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma

Published on: August 3, 2022

3.8K
Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

2.1K

Related Experiment Videos

Last Updated: Mar 9, 2026

Formulating and Characterizing an Exosome-based Dopamine Carrier System
06:08

Formulating and Characterizing an Exosome-based Dopamine Carrier System

Published on: April 4, 2022

3.8K
Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma
07:34

Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma

Published on: August 3, 2022

3.8K
Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

2.1K

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Exosomes are nano-sized extracellular vesicles involved in intercellular communication.
  • Central nervous system (CNS) exosomes are present in cerebrospinal and peripheral fluids.
  • Exosome content changes during disease, indicating potential as biomarkers.

Purpose of the Study:

  • To explore the dual role of exosomes in Parkinson's disease (PD) pathogenesis and therapy.
  • To evaluate exosomes as potential diagnostic biomarkers for PD.
  • To investigate the therapeutic potential of exosomes in PD treatment.

Main Methods:

  • Analysis of exosome content in cerebrospinal fluid and other biological fluids.
  • Investigating exosome-mediated transfer of alpha-synuclein (αsyn).
  • Evaluating therapeutic effects of exosome-delivered agents in PD mouse models.

Main Results:

  • CNS exosomes are implicated in the spread of toxic αsyn aggregates, contributing to PD pathology.
  • Exosomes have demonstrated neuroprotective effects in PD models.
  • Exosomes successfully delivered therapeutic agents like siRNA and catalase to the brain in PD mouse models, showing efficacy.

Conclusions:

  • Exosomes play a complex role in Parkinson's disease, contributing to pathology and offering therapeutic potential.
  • CNS-derived exosomes are valuable candidates for PD biomarker development.
  • Exosomes represent a promising platform for novel diagnostic and therapeutic strategies in PD.